LEE JEFFERSON MCCRANEY DO
Prescription History 1619534021
Psychiatry & Neurology - Neurology in Rapid City, SD


Quality Rating: 97.58 out of 100 score

NPI Status: Active since May 21, 2019

Contact Information

677 CATHEDRAL DR
RAPID CITY, SD
ZIP 57701
Phone: (605) 755-4150

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for LEE JEFFERSON MCCRANEY DO, an active Neurology specialist practicing in Rapid City, SD. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 50 documented patient claims. Among these therapy options, the most frequently utilized medication is Donepezil Hcl, which accounts for 14 claims alone.

Medication Index

No matching medications currently found on file.

Aimovig Autoinjector

Generic Formulation: Erenumab-AooeSpecialty: Neurology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 308
SD State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills31.4
Peer Average Days Supply926
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.7% less volume than the regional standard for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,583.01 across this reporting matrix range.

Provider Avg Cost Per Claim

$780.27

State Avg Cost Per Claim

$845.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to help prevent migraine. This medication may work by changing the amounts of certain natural substances in the brain. Erenumab belongs to a class of drugs known as monoclonal antibodies. Preventing frequent migraine attacks can help improve your ability to concentrate and do your usual tasks.

Donepezil Hcl

Generic Formulation: Donepezil HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 14
30-Day Fills 40.0
Days Supply 1,200
SD State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills62.8
Peer Average Days Supply1,792
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 68.9% less volume than the regional standard for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $358.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.62

State Avg Cost Per Claim

$14.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.

Gabapentin

Generic Formulation: GabapentinSpecialty: Neurology
Provider Metrics Summary
Total Claims 11
30-Day Fills 18.0
Days Supply 540
SD State Average Benchmarks
Peer Average Claims75.0
Peer Average 30-Day Fills112.1
Peer Average Days Supply3,224
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 85.3% less volume than the regional standard for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $371.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$33.77

State Avg Cost Per Claim

$19.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Memantine Hcl

Generic Formulation: Memantine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 14
30-Day Fills 26.8
Days Supply 786
SD State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills45.0
Peer Average Days Supply1,270
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.8% less volume than the regional standard for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $967.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$69.07

State Avg Cost Per Claim

$52.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like LEE JEFFERSON MCCRANEY DO provides transparency into local medical care patterns within Rapid City, SD.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.